Physician profile
Michael Thomas Pyevich
NPI 1043298276
$4,553.94
in general payments reported to CMS, 2019-2025
8 companies · $324 in 2025
The $324 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,867 · 2020: $1,005 · 2021: $834 · 2022: $128 · 2023: $91.81 · 2024: $303 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,936.01 | 2019-2025 | Prophecy, Inbone, Invision |
| Zimmer Biomet Holdings, INC. | $1,109.60 | 2019-2020 | |
| Nuvasive, INC. | $154.99 | 2019-2023 | Reline, Xlif |
| Ethicon US, LLC | $116.23 | 2021-2025 | Ethicon |
| Medical Device Business Services, INC. | $111.23 | 2024 | Ethicon |
| Globus Medical, INC. | $77.97 | 2024-2025 | Alif, Reline |
| Asahi Intecc USA, INC. | $24.78 | 2025 | Asahi Interventional Radiology Wires |
| Smith+Nephew, INC. | $23.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Pyevich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.